NextPlat (NXPL) Q4 2024 earnings summary

Executive summary

• 2024 saw consolidated revenue reach $65.5 million, up 73% year-over-year, driven by healthcare and e-commerce growth, successful acquisitions, and expansion in both segments.

• Completed the merger with Progressive Care and acquired Outfitter Satellite, expanding healthcare and satellite-enabled product offerings.

• Net loss attributable to common shareholders was $14.0 million, or ($0.68) per diluted share, compared to $3.8 million, or ($0.22) per share, in 2023.

• Faced challenges in the healthcare segment due to industry-wide reimbursement pressures, but prescription volumes nearly returned to pre-pandemic levels.

Financial highlights

• Total revenue for 2024 reached $65.5 million, exceeding earlier sales guidance, with healthcare segment outperformance.

• Gross profit margin declined to about 25% for both healthcare and e-commerce segments, impacted by rising costs and pricing pressures.

• Ended 2024 with $20 million in cash, reflecting a net cash burn of $6.3 million, mainly due to non-recurring merger and acquisition expenses.

• Excluding non-recurring items, recurring operating cash outflow was approximately $2 million.

• Net loss attributable to NextPlat Corp was $14.0 million in 2024.

Outlook and guidance

• Targeting cash-neutral operating activities by 2026 and break-even in the healthcare segment.

• Expanded pharmacy service contracts with 340B covered entities and long-term care facilities are expected to drive higher-margin revenue in 2025.

• Florida Sunshine branded vitamins and supplements are expected to launch in the US, EU, and China in late Q2 2025, pending final approvals.

• Plans to increase sales and marketing efforts, especially in healthcare and international e-commerce.

• Anticipates further growth in e-commerce, particularly through new product launches and expanded distribution agreements.